Written Question·Department of Health and Social Care·UIN 3642

Trastuzumab Deruxtecan

Tabled: 30 August 2024

Answered: 10 September 2024

Question

Mr Joshua Reynolds

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of providing access to Enhertu on the NHS for cancer patients.

Answer

Karin Smyth

Decisions on whether new medicines should be routinely funded by the NHS in England are taken by the National Institute for Health and Care Excellence (NICE) on the basis of an evaluation of a treatment’s costs and benefits. NICE’s methods are internation...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 3642) →